Pharmadax Wins U.S. FDA Approval for Generic Seroquel XR to Treat Schizophrenia

☞ | View the text of this post. Exclusively available to ASQ Members.

Chinese pharmaceutical company Pharmadax Inc. disclosed on Tuesday the receipt of U.S. Food and Drug Administration (FDA) for generic equivalent of its first controlled-release product Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

This U.S.FDA approval was also awarded to the company’s subsidiary Pharmadax USA Inc., based in Irvine, California.

Pharmadax has launched the generic Seroquel XR along with its marketing partner, TruPharma LLC.

According to the company, Seroquel

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *